CTLA4 and cancer: The importance of the discovery of inhibiting negative T lymphocyte regulators to treat cancer was recognized in 2018 by the award of the Nobel Prize in Physiology or Medicine to James P. Allison (CTLA-4) and Tasuku Honjo (PD-1).